Board of Directors

Patrick O'Sullivan, Chairman and Chairman of the Compensation Committee
Patrick O'Sullivan is a Pharmaceutical Business Consultant, he is a member of the board of directors of Warner Chilcott Plc and of Chanelle Pharmaceuticals Manufacturing Ltd. Prior to retirement in 2006, Mr O'Sullivan was CEO of the LEO Pharma Group Companies in Ireland and a member of the board of directors of the parent company of the LEO Pharma Group in Denmark. He also served on the boards of The LEO Foundation, LEO Pharmaceuticals Ltd. UK and LEO Pharma SA. France. Mr O'Sullivan holds Bachelor of Commerce and MBA degrees from University College Dublin, he is a registered pharmacist, member and honorary fellow of the Pharmaceutical Society of Ireland and a Knight of the Order of the Dannebrog.

John Lynch, Chief Executive Officer
John Lynch has extensive Pharmaceutical industry experience, with a 20 year career of achievement in many facets of the industry. In that time he has worked in senior positions in operations, business development, sales & marketing and finance. Mr. Lynch has been with Merrion since it commenced operations. Previously, Mr. Lynch was the Chief Executive Officer of JML Healthcare, providing strategic consultancy to blue chip big pharma as well as indigenous life science companies. Previous to that he had a 15 year career with Abbott Laboratories in increasingly responsible management positions, in the USA, UK and in Ireland. Earlier in his career Mr. Lynch held positions with Bayer Diagnostics Limited and Ernst & Young. Mr. Lynch received a B.Comm. from University College Dublin. He is also a fellow of the Institute of Chartered Accountants in Ireland and holds marketing qualifications through the MII. Mr. Lynch also serves on the Tercentenary Board of the School of Medicine at Trinity College and the Board of the Charles Institute at University College Dublin. He is a member of the Taoiseach's Innovation Taskforce.

Harry Stratford, Non-Executive and Chair of the Nominating and Governance Committee
Harry Stratford is the founder and executive chairman of Stratford Healthcare founded in 2008. Mr. Stratford has over 36 years experience in the pharmaceutical industry. He has built two successful publicly listed pharmaceutical companies from the ground up. Prior to Stratford Healthcare's foundation, Mr. Stratford was the founder, CEO and Executive Chairman of Prostrakan Plc, the UK International specialty pharmaceutical company. He founded Shire Pharmaceuticals in 1986 and was CEO for almost a decade. Mr. Stratford holds a B.Sc. in Chemistry from the University of London and was awarded an OBE in 2007 New Year's Honours list for his contribution to the Scottish Life Sciences Industry.

Michael J. McKenna, PhD, Non Executive
Dr. McKenna served as our chairman from February 2008 to February 2009, as our chief executive officer from April 2004 to February 2008, and on our board of directors since April 2004. From September 1999 to March 2004, Dr. McKenna served as vice president of science and technology at A.M. Pappas & Associates, LLC, a life sciences venture development company. Previously, he owned and operated Pharmaceutical Consulting Services, advising the biopharmaceutical industry in drug development and drug safety. Prior to this he was Vice President, Drug Development at Parke Davis. Dr. McKenna also held numerous scientific and managerial positions in the toxicology laboratories of The Dow Chemical Company and Parke Davis. Dr. McKenna received a B.A. in English from St. John Fisher College and a Ph.D. in Toxicology from the University of Rochester School of Medicine and Dentistry.

Peter Thornton, Non-Executive and Chair of the Audit Committee
Mr. Thornton is currently SVP, Head of Product, Technology and Business Development Elan Drug Technologies. He was formerly president and chief operating officer of Circ Pharma Limited, a specialty pharmaceutical product development company, senior vice president and chief financial officer of Antigenics Inc., a NASDAQ listed biotechnology company, as well as senior vice president of business operations at Elan Corporation plc. He previously held a series of other senior finance and operations roles with Elan. Prior to joining Elan in 1994, Mr. Thornton worked with the international accounting firm KPMG in Dublin and Paris. Mr. Thornton is a director of US based Antigenics Inc. and Cydex Inc., a specialty pharmaceutical company. Mr. Thornton earned his bachelor's degree in commerce from University College, Cork, Ireland, and is a fellow of the Institute of Chartered Accountants in Ireland.

Anthony Carragher, Non-Executive
Mr. Carragher has his own consultancy and advisory business that focuses primarily on International financial and property investments. He is also a director of Eurocommerce, Growcorp, and The Vaults. Mr. Carragher is a qualified chartered accountant and has spent over 15 years in the corporate finance and investment area. He is also CFO to a major Irish charitable organisation.

Michael Donnelly, Non-Executive
Mr. Donnelly is Chairman of Growcorp Group Ltd. Prior to Growcorp, he was Vice President and General Manager of a medical products company in Cincinnati, Ohio from 1996-1998, Vice President of IEP Group Research Triangle Park, NC from 1993-1996, Professor of Pediatrics, College of Medicine, University of Cincinnati, Ohio, and Director of Bioengineering Research at the Perinatal Research Institute, Cincinnati, Ohio from 1986-1996. Mr. Donnelly sits on the Boards of Growcorp Group, Growcorp (GP), Merrion Biopharma, Ltd., Gas Sensor Solutions, Fluorocap and Pharmatrin, Orakine, North Wall General Partners, Neutekbio, Irish Venture capital Association and Irish Biotechnology Association and is the Managing Partner of the European Bioscience Fund.

Fintan Maher, Non-Executive
Mr. Maher is the Managing Director of Northwall General Partner Ltd., the General Partner of Growcorp Lifescience Limited Partnership an investment fund focused on Lifescience investments, Mr Maher has held this position since October 2004. He has 18 years Investment experience covering Private Wealth Management, Private Equity and Investment Management. From 1999 to 2004 Mr. Maher was the Investment Manager for Irelandia Investments Ltd., the family office of the Ryan Family. He previously held a series of senior roles in Investment Management in the US and Ireland. Mr. Maher sits on the Boards of Growcorp Group, Growcorp (GP), North Wall General Partner Ltd., Merrion Pharmaceuticals Ltd., Gas Sensor Solutions, Orakine and nEUtekbio. Mr. Maher earned a Bachelor of Commerce from University College Dublin, and is a member of The Society of Investment Analysts in Ireland (SIAI) a member society of the CFA Institute.